Riverwater Partners’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,714
| Closed | -$266K | – | 188 |
|
|
2023
Q4 | $266K | Sell |
1,714
-435
| -20% | -$67.4K | 0.21% | 157 |
|
|
2023
Q3 | $320K | Buy |
2,149
+478
| +29% | +$71.3K | 0.29% | 120 |
|
|
2023
Q2 | $225K | Hold |
1,671
| – | – | 0.2% | 163 |
|
|
2023
Q1 | $266K | Sell |
1,671
-365
| -18% | -$58.2K | 0.24% | 138 |
|
|
2022
Q4 | $329K | Sell |
2,036
-3
| -0.1% | -$485 | 0.28% | 110 |
|
|
2022
Q3 | $274K | Sell |
2,039
-69
| -3% | -$9.27K | 0.27% | 120 |
|
|
2022
Q2 | $323K | Buy |
+2,108
| New | +$323K | 0.33% | 109 |
|
|
2022
Q1 | – | Sell |
-2,681
| Closed | -$363K | – | 104 |
|
|
2021
Q4 | $363K | Buy |
+2,681
| New | +$363K | 0.32% | 111 |
|